Nitric oxide (NO) is thought to play an essential role in neuronal processing, but the downstream mechanisms of its action remain unclear. We report here that NO analogs reduce GABAgated currents in cultured retinal amacrine cells via two distinct, but convergent, cGMP-dependent pathways. Either extracellular application of the NO-mimetic S-nitroso-N-acetylpenicillamine (SNAP) or intracellular perfusion with cGMP depressed GABA currents. This depression was partially blocked by a pseudosubstrate peptide inhibitor of cGMP-dependent protein kinase (PKG), suggesting both PKG-dependent and independent actions of cGMP. cAMP-dependent protein kinase (PKA) is known to enhance retinal GABA responses.
Nitric oxide (NO) was first identified as a factor released by endothelial cells that relaxes vascular smooth muscle (Palmer et al., 1987) . Subsequently, its synthetic enzyme, nitric oxide synthase (NOS/ NADPH diaphorase), has been identified in almost every region of the C NS (Dawson et al., 1991) . As a gas, NO is able to cross cell membranes freely, giving rise to the notion that NO might act as a retrograde messenger at synapses from which it is released and possibly at neighboring synapses as well.
One of the best-documented targets of NO is an intracellular soluble guanylate cyclase (sGC), the enzyme that synthesizes cGMP (Schmidt et al., 1993) . cGM P can bind to at least three distinct classes of proteins. First, cGM P can gate channels directly. C yclic nucleotide-gated channels have been found in cells in both the C NS and PNS (Fesenko et al., 1985; Nakamura and Gold, 1987; Naw y and Jahr, 1990; Goulding et al., 1992; Schmidt et al., 1993; Bourgeois and Rakic, 1996; Meissirel et al., 1997) . Second, cGM P can activate cGM P-dependent protein kinase (PKG) (Scott, 1991) . Finally, two subtypes of phosphodiesterases (PDE) are known to be regulated by cGM P. T ype II PDE (GS-PDE) is stimulated by binding cGM P, whereas type III PDE (GI-PDE) is inactivated when cGM P is bound (Beavo et al., 1971a,b) .
Cyclic nucleotides are well-established modulators of ion channels in retinal neurons. Elevated levels of cAM P decrease electrotonic coupling among both horizontal and amacrine cells Schwartz, 1989, 1992; Mills and Massey, 1995) .
Similarly, cGMP uncouples teleost horizontal cells and reduces heterologous coupling between mammalian bipolar and AII amacrine cells Schwartz, 1989, 1992; Mills and Massey, 1995) . Although both cAMP and cGMP reduce gap junction coupling, they seem to act antagonistically in regulating the activity of glutamate receptors. It has been shown that cAMP enhances glutamate-evoked currents in horizontal cells (Knapp and Dowling, 1987; Liman et al., 1989) . In contrast, cGMP reduces such currents (McMahon and Ponomareva, 1996) .
In retinal neurons, cAMP also enhances GABA-gated chloride currents (Feigenspan and Bormann, 1994; Veruki and Yeh, 1994) . Despite the recognized importance of NO and the observation that cAMP and cGMP act on common targets, relatively little is known concerning cGMP-dependent modulation of GABA A receptor function. However, studies in the nucleus tractus solitarius Miller, 1993, 1995) , cerebellar granule cells (Robello et al., 1996) , and hippocampus (Zarri et al., 1994) suggest that cGMP may downregulate GABA A receptor function. Therefore, the present study was undertaken to examine how cGMP might modulate retinal GABA A receptor function and to elucidate which enzymes mediate its effects.
MATERIALS AND METHODS
Cell culture. Retinas were removed from newborn L ong-Evans-hooded rats after cryoanesthesia and were incubated for 45-60 min at 37°C in DM EM with H EPES (Mediatech, Washington, DC), supplemented with papain (Worthington, Freehold, NJ) at 6 units/ml and cysteine at 0.2 mg /ml. Papain was inactivated by replacing the enzyme solution with medium of the following composition: DM EM plus H EPES, 0.1% mito ϩ serum extender (Collaborative Research, Bedford, M A), 5% heatinactivated fetal calf serum (HI FC S), 0.75% penicillin -streptomycinglutamine mix (Life Technologies), and 7.5% sterile water to lower osmolarity. Retinas were triturated through a fire-polished Pasteur pipette, plated onto glass coverslips pretreated with poly-D-lysine (0.1 mg /ml), and maintained in medium supplemented with 15 mM KC l, 2 ng /ml basic fibroblast growth factor (bFGF; Life Technologies), and 100 ng /ml brain-derived neurotrophic factor (BDN F; Regeneron /Amgen).
At 72 hr after plating, cells were treated with the antimitotics 5-fluoro-2-deoxyuridine (0.01 mg /ml) and uridine (0.026 mg /ml) for 24 hr. Subsequently, every 3rd day, 25% of the culture medium was exchanged for fresh medium. C ells were used for recording after 10 -17 d in vitro.
Immunoc ytochemistr y. Coverslips containing primary cultured neurons were washed three times with D-PBS, fixed in 4% paraformaldehyde for 15 min at room temperature and with 100% methanol at Ϫ10°C for 15 min, rinsed with Dulbecco's PBS (D-PBS), and then incubated overnight at 8°C with primary antibody. Anti-HPC -1 (Sigma, St. L ouis, MO), anti-GABA (Chemicon, Temecula, CA), and anti-neurofilament 145 (N F145) (Chemicon) were diluted 1:100 in D-PBS, 10% fetal calf serum, and 0.5% Triton X-100. After 12-24 hr, coverslips were rinsed twice with D-PBS, incubated for 90 min in TRI TC -or FI TC -conjugated secondary antibody (Chemicon) diluted 1:100 at room temperature, rinsed twice in D-PBS and sterile water, and mounted onto glass slides using Prolong AntiFade (Molecular Probes, Eugene, OR). For labeling with antiThy1.1 IgM (gift of Dr. David Weinstein), live cells were incubated with primary antibody diluted 1:50 in normal culture medium for 60 min at 37°C, followed by rinsing twice in D-PBS and fixing with 4% paraformaldehyde for 5 min at room temperature. Labeling with secondary antibody was as detailed above. C ells were viewed with a Z eiss Axiovert 135 microscope equipped with a 100 W mercury lamp (HBO 100).
Electrophysiolog y. Recordings were made using an Axopatch 1-D amplifier, Digidata 1200 data acquisition board, and Axobasic software (Axon Instruments). Patch electrodes were pulled from standard hematocrit tubing (V W R Scientific) using a Narishige PP-83 vertical two-stage puller and were fire polished (Narishige MF-83) to a resistance of 2-3 M⍀. Recordings typically had series resistances of 10 -20 M⍀, and those that exceeded 20 M⍀ or varied by Ͼ10% during the experiment were discarded.
The standard extracellular solution contained 160 mM NaC l, 2 mM CaCl 2 , and 5 mM H EPES. The gluconate-based intracellular solution was as follows: 110 mM potassium gluconate, 40 mM KC l, 10 mM EGTA, 5 mM H EPES, 2 mM Mg-ATP, and 250 M Na-GTP, pH 7.3. Mannitol was added to adjust the osmolarity. The phosphate-based intracellular solution contained potassium phosphate monobasic (120 -140 mM). 1 H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) was stored at Ϫ20°C as a 10 mM stock in DMSO. 8-Bromo-cGM P (8Br-cGM P), 8-bromoinosine 3Ј,5Ј-cyclic monophosphate (8Br-cIM P), and S-nitroso-N-acetylpenicillamine (SNAP) were stored frozen (Ϫ20°C) as a dry powder and were made up each day in the standard extracellular solution. SNAP was prepared as an 11% (w/ v) stock in DMSO (i.e., 1.1 mg of SNAP/10 l of DMSO). Sodium nitroprusside (SN P) was made every 3-5 hr. Final DMSO concentrations never exceeded 0.1%. ATP, GTP, cAM P, cGM P, and cGM P-dependent protein kinase inhibitory peptide (GK I P; ArgLys-Arg-Ala-Arg-Lys-Glu; Peninsula Labs) were stored at Ϫ20°C as 1000ϫ stocks in distilled water. 1-Methyl-3-isobutylxanthine (I BMX) and microcystin (Research Biochemicals, Natick, M A) were stored at Ϫ20°C as 1000ϫ stocks in dry DMSO. Drugs were delivered through a pair of parallel, f used silica flow pipes (375 or 500 m inner diameter: Polymicro Technologies). Each flow pipe was supplied by six separate reservoirs, each with its own control valve to feed fluid through a six-to-one tubing manifold (Warner Instruments). The flow pipe apparatus was under computer control and was driven by a piezo bimorph actuator (Morgan Matroc). This apparatus is an adaptation of that used by Lester et al. (1990) . With the larger flow pipes, 10 -90% whole-cell solution exchanges were achieved in Ͻ2.5 msec.
In experiments in which either cGM P or microcystin was included in the internal solution, the tip of the recording pipette was filled with control solution, and the shank was filled with either the cGM P-or microcystin-containing solution. This delayed the entrance of the test compound into the cell for several minutes, during which time E C l was observed to shift from Ϫ60 to Ϫ30 mV. GABA responses in cells held at Ϫ60 mV displayed a "run-up" in amplitude during this period of chloride shifting, a consequence of an increased chloride driving force. This run-up period was succeeded by 1-3 min of stable, "baseline" GABA responses. Time 0 was defined as the last point of this baseline period.
RESULTS

Identification of amacrine cells
Amacrine cells were distinguished from ganglion and horizontal cells in culture using both morphological and physiological criteria. Virtually all of the large multipolar cells Ͼ12 m (280 Ϯ 17 cells/mm 2 ; n ϭ 6 cultures) were immunoreactive for HPC-1, an amacrine cell marker (Barnstable et al., 1985) . In contrast, Ͻ1% of all cells were labeled with medium weight (145 kDa) neurofilament (NF145), a cytoskeletal protein expressed by both horizontal cells and ganglion cell axons (Shaw et al., 1984) . Moreover, only 5% (15 Ϯ 4; n ϭ 6) of large (Ͼ12 m) neurons expressed Thy1.1, an antigenic marker for ganglion and displaced amacrine cells. Fewer than one fifth of these Thy1.1 positive cells (i.e., 1% of all cells) exhibited a robust, nonpunctate staining pattern typical of ganglion cells (Taschenberger and Grantyn, 1995) . Taken together, these data suggest that nearly all large cells were amacrine and not ganglion or horizontal cells. This relative homogeneity of cell type may have been the result of maintaining the cultures in a medium of high osmolarity (340 -385 mOsm), which has been reported to prevent ganglion cell survival (Meyer-Franke et al., 1995) . Figure 1 A shows a typical cell that was immunoreactive for GABA, the neurotransmitter used by amacrine cells (VersauxBotteri et al., 1989; Wu, 1992) . Cells with this morphology had membrane potentials of Ϫ30 to Ϫ40 mV and rapidly accommodating action potentials, consistent with the physiological properties of amacrine cells (Taschenberger and Grantyn, 1995) . Under whole-cell voltage clamp, all cells of the type shown in Figure 1 A (7-14 d in culture) responded to GABA ( Fig. 1 B, overhead bar) with a desensitizing inward current that reversed at Ϫ30 mV, the predicted E C l , and that was blocked by 100 M bicuculline, suggesting that these cells expressed primarily GABA A receptors.
From the fit of the dose-response relation shown in Figure 1C , we obtained an EC 50 of 40 Ϯ 2 M (n ϭ 8) and a Hill coefficient of 1.8 Ϯ 0.2. Subsequent experiments were performed using 50 M GABA, a concentration near the EC 50 for these receptors. The Hill coefficient is in good agreement with the value of 1.9 obtained for GABA A currents in amacrine cells from rat retinal slice (Feigenspan and Bormann, 1994) . The EC 50 for GABA in that study was found to be 72 M, although agents that promote phosphorylation by cAMP-dependent protein kinase (PKA) shifted the EC 50 to 45 M (Feigenspan and Bormann, 1994) , close to the value obtained in the present study.
NO agonists depress GABA currents
We examined the potential role of NO in regulating GABA A receptor-gated currents using two NO analogs, SNP and SNAP, which activate soluble guanylate cyclase (Bohme et al., 1984; Schmidt et al., 1993) . GABA was applied for 500 msec at intervals of 20 sec, a protocol that avoids cumulative desensitization associated with longer or more frequent GABA applications. When the control solution was switched to a solution containing 50 M SNP, the GABA response was reversibly reduced. In four cells, SNP reduced GABA responses by 29 Ϯ 7% (Fig. 2 A) .
SNAP also depressed GABA currents (Fig. 2 B) . Application of 50 M SNAP produced a depression of 24 Ϯ 4%, whereas 100 M SNAP depressed GABA currents by an average of 34 Ϯ 4%. One hundred micromolar SNAP seemed to be near saturating as a fivefold higher concentration produced little further increase in depression (37 Ϯ 2%). DMSO (0.1%) alone did not produce any consistent reduction of GABA responses. Measurement of I-V relations indicated that depression of the GABA response by SNP or SNAP was not because of a shift in the reversal potential of the response (data not shown). With continuous application of either SNAP or SNP, recovery of the GABA response was often observed. The reason for this recovery is not clear.
If NO agonists depress GABA currents by activating sGC, then direct application of cGMP should similarly depress them. GABA currents were elicited as before, and cells were perfused with the membrane-permeant cGM P analog 8Br-cGMP (Fig.  2C) . In eight cells, 1 mM 8Br-cGM P decreased the amplitude of the GABA response by an average of 41 Ϯ 9%. Thus both cGMP itself and compounds that elevate intracellular cGM P depressed GABA responses.
To test whether SNAP reduced GABA currents by activating sGC, we first preincubated cells in 1 M ODQ, a specific inhibitor of sGC (Garthwaite et al., 1995) . In the presence of ODQ, there was a 20 Ϯ 2% enhancement of the GABA currents, possibly because of inhibition of a basal guanylate cyclase activity and subsequent reduction in cGM P-mediated depression. Depression of GABA current by 8Br-cGM P was not significantly affected by ODQ, as would be expected if raising intracellular levels of cGMP directly circumvents the need for guanylate cyclase activity. In the presence of ODQ, 8Br-cGM P depressed the GABA response by 35 Ϯ 4% (n ϭ 6; Fig. 3A) . ODQ significantly reduced the depression of GABA current by SNAP at all three concentrations of SNAP that were tested (Fig. 3B) . The efficacies of ODQ against either a submaximal SNAP concentration (50 M, 46%) or a near-saturating concentration (500 M, 44%) were similar. ODQ is reported to block 75% of SNAP-induced sGC activity, measured biochemically, (Garthwaite et al., 1995) compared with the 45% efficacy obtained in this study. The difference suggests that there may be an additional component of SNAPinduced depression of GABA currents in amacrine cells that is independent of sGC (Pozdnyakov et al., 1993; Brune et al., 1994; Zoche and Koch, 1995) .
A component of cGMP-induced depression requires PKG
One target of cGM P is PKG. To determine whether PKG activation was responsible for depression of GABA currents, we blocked the activation of PKG in individual amacrine cells by including a pseudosubstrate inhibitory peptide (GK I P) in the intracellular patch pipette solution (Glass, 1983; Glass and Smith, 1983; McMahon and Ponomareva, 1996) . The average size of GABA currents in cells internally perf used with 50 M GKIP for 10 min (867 Ϯ 208 pA) was not significantly different than that in untreated cells (835 Ϯ 136 pA). However, SNAP produced only an 18 Ϯ 2% mean depression in six cells internally perfused with GKIP, approximately half of the SNAP-induced depression observed in control cells (Fig. 4) .
Similar effects of GKIP were observed when cells were internally dialyzed with cGMP (Fig. 5) . Twenty-five minutes after achieving whole-cell recording, GABA responses in cells perfused with 1 mM cGMP were depressed by 58 Ϯ 3% (n ϭ 8), compared with 10 Ϯ 1% in the control solution (n ϭ 11). In the presence of GKIP, cGMP decreased GABA-evoked currents by 35 Ϯ 10% (n ϭ 8) over the same period. Regardless of whether intracellular cGMP was elevated directly by addition to the pipette or indirectly with an analog of NO, inhibition of PKG blocked ϳ50% of the cGMP-induced depression of GABA currents.
Depression of GABA currents was also observed when phosphatase activity was inhibited either with a phosphate-based internal solution (Kennelly et al., 1993; Thiebart-Fassy and Hervagault, 1993; Weiner et al., 1993; Caselli et al., 1994; Gao and Fonda, 1994; Bernardi et al., 1995) or with 1 M microcystin-LR, an inhibitor of type 1 and 2A phosphatases (Honkanen et al., 1990) . Data are summarized in Figure 6 A. Both phosphate (39 Ϯ 2%; n ϭ 5) and microcystin (43 Ϯ 5%; n ϭ 12) produced a significant depression of the GABA response compared with that seen in the control (10 Ϯ 1%; n ϭ 11).
Run-down of GABA currents during phosphatase inhibition might be expected if endogenous levels of cGMP are sufficiently high to activate PKG or if basal PKG activity is sufficient to phosphorylate targets when counteracting phosphatases are inhibited. Alternatively, run-down may be caused by other factors not related to PKG. To distinguish between these two possibilities, we included the PKG peptide inhibitor in the phosphatebased internal solution. Run-down of GABA currents because of high phosphate was almost completely blocked by inhibiting PKG (Fig. 6 B) . The observation that inhibition of PKG was sufficient to completely prevent depression of GABA currents in response to basal, but not stimulated, levels of cGMP prompted us to consider the possibility that cGM P could be acting on additional targets besides PKG.
A second component of cGMP-induced depression of GABA currents requires PDE activation
cGMP is known to activate a cGM P-stimulated cAMPphosphodiesterase (GS-PDE), an effect that is independent of PKG activation (Beavo et al., 1994) . Because cAMP and its analogs have been shown to potentiate amacrine cell GABA responses (Feigenspan and Bormann, 1994) , activation of GS-PDE by cGMP could indirectly depress GABA currents by hydrolyzing intracellular cAMP. cIMP is reported to be two orders of magnitude more potent at activating GS-PDE than at activating PKG (Miller et al., 1973) . We therefore tested the possibility that selective activation of GS-PDE with cIMP might depress GABA currents. Application of a cell permeant analog of cIMP, 8Br-cIMP (250 SNP reversibly depressed the GABA response by 33% in this cell and by 29 Ϯ 7% (n ϭ 4) on average. B, SNAP (500 M) reversibly depressed the GABA response by 38% in this cell and by 37 Ϯ 2% (n ϭ 6) on average. C, 8Br-cGMP (1 mM) reversibly depressed the GABA response by 42% in this cell and by 41 Ϯ 9% (n ϭ 8) on average. Figure 3 . SNAP depressed GABA A currents via activation of soluble guanylate cyclase. A, ODQ does not block cGM P-mediated depression of the GABA response. C ells were internally dialyzed with control gluconate solution and externally perf used with ODQ (1 M). Application of ODQ potentiated the GABA A currents by 20 Ϯ 2% (n ϭ 6). After a 5 min perf usion with ODQ alone, cells were perf used with a combination of ODQ and 8Br-cGM P (1 mM) (overhead bar). 8Br-cGM P depressed the GABA response by 35 Ϯ 4% from the new, elevated baseline (n ϭ 6). B, Summary of the dose-dependent depression of the peak GABA current by SNAP, an NO agonist, is shown. At the three concentrations tested, SNAP (500, 100, and 50 M) depressed the GABA-evoked current by 37 Ϯ 2% (n ϭ 6), 34 Ϯ 4% (n ϭ 8), and 24 Ϯ 4% (n ϭ 5), respectively, when applied to a naive cell (control, solid bar; mean Ϯ SEM). Immediately after a 10 min preincubation with the sGC inhibitor ODQ (1 M; hatched bar), SNAP depressed the GABA-evoked currents by 16 Ϯ 5% (n ϭ 3), 17 Ϯ 4% (n ϭ 8), and 11 Ϯ 2% (n ϭ 5), respectively (*p ϭ 0.05, unpaired two-tailed Student's t test, compared with control in SNAP alone).
M), depressed GABA currents by an average of 18 Ϯ 6% (Fig.  7B , hatched bar; n ϭ 6). The inhibition of GABA currents by 8Br-cIM P in an individual cell is shown in Figure 7A . When cells were internally perf used with the phosphate-based internal solution and 10 M cAM P to ensure maximal PK A-dependent phosphorylation (Simmons and Hartzell, 1988) , 8Br-cIM P depressed the peak GABA current by 37 Ϯ 3% (Fig. 7B , lef t gray bar; n ϭ 5). The tendency for the response to relax during prolonged 8Br-cIM P exposure has also been observed for hippocampal calcium currents under similar experimental conditions (Doerner and Alger, 1988) . The depression induced by 8Br-cIMP was blocked by internal perf usion of the PDE inhibitor I BMX (Fig.  7B , right gray bar; n ϭ 3). In a separate group of cells dialyzed with I BMX and the phosphate-based internal solution, the rundown of GABA A currents over 20 min was 27 Ϯ 7% (n ϭ 5). This difference was not statistically significant when compared with cells perfused with phosphate-based solution alone (28 Ϯ 4%; n ϭ 5). Our results suggest that amacrine cells may contain a PDE that is inhibited by IBMX and stimulated by cIMP, resulting in a depression of GABA currents. Inhibition of both PKG and PDE blocked most of the SNAPinduced depression that was not blocked by PKG inhibition alone. We compared the depressant effects of 100 M SNAP when . GK I P partially blocks cGM P-induced depression. A, GABAevoked currents immediately after establishment of recording and after 20 min are shown in three cells perf used with either control solution, 1 mM cGM P, or cGM P plus 50 M GK I P. Overhead bars indicate timing of GABA application. B, Inclusion of cGM P in the recording pipette caused a 58 Ϯ 3% (n ϭ 8) decline in the GABA response compared with a 10 Ϯ 1% (n ϭ 11) decline in control cells over the course of 25 min. When cells were dialyzed with cGM P plus GK I P, GABA responses declined by 35 Ϯ 10% (n ϭ 8) over the same time period, about one-half of the reduction observed in the presence of cGM P alone. For each cell, the amplitude of the peak GABA response was normalized to the initial amplitude. Normalized amplitudes were then averaged and binned at 2 min intervals. The points plotted are mean Ϯ SEM of each bin.
GKIP alone was added to the internal solution with that observed when 1 mM I BMX was added together with GK I P. We used twice the concentration of GK I P (100 M) used in previous experiments to help insure that PKG was maximally blocked. The averaged time course and peak inhibition of SNAP under each condition are shown in Figure 8 . SNAP depressed the GABA current to a lesser degree (21 Ϯ 3%; n ϭ 15) in cells perfused with GK I P than in control cells (34 Ϯ 4%; n ϭ 10). Moreover, internal perf usion with a combination of GK I P and I BMX in 14 cells f urther limited the SNAP-induced depression of the GABA response to 11 Ϯ 2%.
DISCUSSION
Our findings support the following NO-mediated cascade regulating GABA A receptors on retinal amacrine cells. NO stimulates soluble guanylate cyclase, which raises the intracellular concentration of cGM P. cGM P increases PKG-mediated phosphorylation and concomitantly decreases PKA phosphorylation, via stimulation of GS-PDE. These events act synergistically to depress GABA A receptor-gated currents. With continuous application of NO agonists, recovery of the GABA response was often observed.
Of the seven known forms of PDE, two are regulated by cGMP. Although both catalyze the hydrolysis of cAMP, the type III form is inhibited by cGMP, whereas the type II form (GS-PDE) is stimulated by cGMP (Beavo et al., 1971a,b) . There is precedence for a GS-PDE indirectly modulating ion channel function. Calcium currents (I C a ) in cardiac myocytes (Hartzell and Fischmeister, 1986) and hippocampal CA1 pyramidal cells (Doerner and Alger, 1988) are potentiated by PKA phosphorylation, yet they are depressed by cGMP via PKG-independent activation of a GS-PDE. In these cells, cGMP stimulation of GS-PDE lowers intracellular cAMP, subsequently reducing PKA activity. Figure 6 . Phosphatase inhibition unmasks PKG-dependent run-down of the GABA response. A, Summary of normalized GABA currents recorded after 30 min in cells internally perf used with control (gluconate), phosphate, or gluconate plus 1 M microcystin-LR. After 30 min, GABA responses recorded in control cells were reduced by 10 Ϯ 1% (n ϭ 11) compared with reductions of 39 Ϯ 2% in high phosphate (n ϭ 5) and 43 Ϯ 5% (n ϭ 12) in microcystin, consistent with the unmasking of a kinasedependent mechanism (*p ϭ 0.05, one-way ANOVA, compared with control). B, Averaged time course of six cells dialyzed with GK I P (50 M) plus high phosphate and five cells dialyzed with high phosphate alone. GKIP prevented run-down of the GABA response in high phosphate solution. GABA currents were reduced by 12 Ϯ 2% in cells dialyzed with GKIP plus phosphate compared with 10 Ϯ 1% in cells with gluconate. Figure 7 . Activation of phosphodiesterase also suppresses GABA currents. A, Application of 8Br-cIM P (overhead bar) to a cell perfused with phosphate plus 10 M cAM P produced a rapid decline in the GABAevoked current. All currents were normalized to the amplitude of the current just before the application of 8Br-cIM P. The insets are currents evoked by 250 msec applications of 50 M GABA to a representative cell before, during, and after the application of 8Br-cIM P, as indicated by the numbers. B, Application of the GS-PDE activator 8Br-cIMP (500 M) depressed GABA-evoked currents by 18 Ϯ 6% in cells perfused with gluconate (n ϭ 6; hatched bar) and by 37 Ϯ 3% in cells perfused with phosphate plus cAM P (n ϭ 5; lef t gray bar). In contrast, 8Br-cIMP did not diminish the GABA current in cells perf used with I BMX, consistent with the idea that 8Br-cIM P activated PDE (n ϭ 3; right gray bar; p ϭ 0.05, unpaired two-tailed Student's t test).
Two lines of evidence support our contention that regulation of amacrine cell GABA-gated currents by GS-PDE may be analogous to regulation of calcium currents in hippocampal pyramidal cells and cardiac myocytes. First, the application of 8Br-cIMP, a selective activator of GS-PDE, produced a marked depression of GABA currents. This effect was blocked by the broad-spectrum PDE inhibitor I BMX, consistent with an action on GS-PDE (Fig.  7) . Second, intracellular dialysis with I BMX also blocked a substantial fraction of the SNAP-induced depression that was not blocked by PKG inhibition alone (Fig. 8) . However, because neither inhibition of sGC nor the combined inhibition of PKG and PDE completely blocked SNAP-induced depression of GABA currents, it is possible that SNAP might also inhibit GABA currents via a third mechanism that is completely independent of cGM P, perhaps by acting directly on the channel, as has been demonstrated for olfactory cAM P-gated channels (Broillet and Firestein, 1996) .
When the phosphorylation-dependent component of the depression was pharmacologically isolated by inhibiting phosphatases, GABA currents ran down with time. Because there was no source of exogenous cGMP in this experiment, there must have been sufficient active PKG to produce a net increase in phosphorylation while phosphatases were inhibited. In phosphate, rundown of I GABA was slow, ϳ1.5 pA/min, and this may reflect a very low level of basal PKG activity. Our data also suggest that, in the absence of cGMP stimulation, GS-PDE is inactive, because inhibition of PKG by GKIP was sufficient to block nearly all of the run-down. One possible explanation for this finding is that higher concentrations of cGMP are needed to activate GS-PDE than PKG. Biochemical studies have suggested that PKG can be activated by concentrations of cGMP that are between 10 and 100 times lower than those that are required to activate GS-PDE (Martins et al., 1982;  for PDE review, see Butt et al., 1993) . Addition of extracellular cGMP (Fig. 4) or SNAP (Fig. 4) produced a depression of GABA currents that was only partially blocked by inhibition of PKG, presumably because the intracellular levels of cGMP were increased sufficiently to activate both GS-PDE and PKG. It seems unlikely that the partial block of SNAP-induced I GABA is attributable to incomplete PKG inhibition by GKIP, because doubling the concentration of the peptide inhibitor from 50 to 100 M did not decrease the suppression of GABA currents by SNAP. Second, GKIP is a pseudosubstrate inhibitor, acting at the PKG catalytic site rather than at the regulatory site. Thus, it is not competitively antagonized by increasing intracellular cGMP. Several reports have defined a mechanism by which activators of adenylate cyclase, such as dopamine, enhance GABA A currents in mammalian retina Yeh, 1992, 1994; Feigenspan and Bormann, 1994) . The present study suggests that activators of guanylate cyclase, such as NO, do just the opposite. The enzymes that synthesize dopamine and NO are both located in subpopulations of GABAergic amacrine cells (Wassle and Chun, 1988; Vaney and Young, 1988; Darius et al., 1995) . Thus, GABAergic transmission in the inner retina may be modulated in a push-pull manner by activators of adenylate cyclase such as dopamine or vasoactive intestinal peptide on the one hand and by NO on the other. 
